186 related articles for article (PubMed ID: 19900544)
21. Characterization of 9-nitrocamptothecin-in-cyclodextrin-in-liposomes modified with transferrin for the treating of tumor.
Chen J; Lu S; Gu W; Peng P; Dong J; Xu F; Yang X; Xiong Z; Yang X
Int J Pharm; 2015 Jul; 490(1-2):219-28. PubMed ID: 26004006
[TBL] [Abstract][Full Text] [Related]
22. Fabrication of cationic nanomicelle from chitosan-graft-polycaprolactone as the carrier of 7-ethyl-10-hydroxy-camptothecin.
Duan K; Zhang X; Tang X; Yu J; Liu S; Wang D; Li Y; Huang J
Colloids Surf B Biointerfaces; 2010 Apr; 76(2):475-82. PubMed ID: 20047821
[TBL] [Abstract][Full Text] [Related]
23. Novel cyclodextrin nanosponges for delivery of calcium in hyperphosphatemia.
Shende P; Deshmukh K; Trotta F; Caldera F
Int J Pharm; 2013 Nov; 456(1):95-100. PubMed ID: 23954237
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of linear, beta-cyclodextrin-based polymers and their camptothecin conjugates.
Cheng J; Khin KT; Jensen GS; Liu A; Davis ME
Bioconjug Chem; 2003; 14(5):1007-17. PubMed ID: 13129405
[TBL] [Abstract][Full Text] [Related]
25. Preparation and characterization of cyclodextrin nanosponges for organic toxic molecule removal.
Varan C; Anceschi A; Sevli S; Bruni N; Giraudo L; Bilgiç E; Korkusuz P; İskit AB; Trotta F; Bilensoy E
Int J Pharm; 2020 Jul; 585():119485. PubMed ID: 32497732
[TBL] [Abstract][Full Text] [Related]
26. Amorphous solid dispersion studies of camptothecin-cyclodextrin inclusion complexes in PEG 6000.
Fatmi S; Bournine L; Iguer-Ouada M; Lahiani-Skiba M; Bouchal F; Skiba M
Acta Pol Pharm; 2015; 72(1):179-92. PubMed ID: 25850214
[TBL] [Abstract][Full Text] [Related]
27. Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model.
Cırpanlı Y; Allard E; Passirani C; Bilensoy E; Lemaire L; Calış S; Benoit JP
Int J Pharm; 2011 Jan; 403(1-2):201-6. PubMed ID: 20951783
[TBL] [Abstract][Full Text] [Related]
28. Fabrication of nanomicelle with enhanced solubility and stability of camptothecin based on alpha,beta-poly[(N-carboxybutyl)-L-aspartamide]-camptothecin conjugate.
Fan N; Duan K; Wang C; Liu S; Luo S; Yu J; Huang J; Li Y; Wang D
Colloids Surf B Biointerfaces; 2010 Feb; 75(2):543-9. PubMed ID: 19846282
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of EDTA Dianhydride Versus Diphenyl Carbonate Nanosponges for Curcumin.
Mashaqbeh H; Obaidat R; Al-Shar'i NA
AAPS PharmSciTech; 2022 Aug; 23(7):229. PubMed ID: 35974237
[TBL] [Abstract][Full Text] [Related]
30. CPT loaded nanoparticles based on beta-cyclodextrin-grafted poly(ethylene glycol)/poly (L-glutamic acid) diblock copolymer and their inclusion complexes with CPT.
Du F; Meng H; Xu K; Xu Y; Luo P; Luo Y; Lu W; Huang J; Liu S; Yu J
Colloids Surf B Biointerfaces; 2014 Jan; 113():230-6. PubMed ID: 24096159
[TBL] [Abstract][Full Text] [Related]
31. Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery.
Cirri M; Bragagni M; Mennini N; Mura P
Eur J Pharm Biopharm; 2012 Jan; 80(1):46-53. PubMed ID: 21839833
[TBL] [Abstract][Full Text] [Related]
32. Formulation Optimization and Biopharmaceutical Evaluation of Imatinib Mesylate Loaded β-cyclodextrin Nanosponges.
Kamble M; Zaheer Z; Mokale S; Zainuddin R
Pharm Nanotechnol; 2019; 7(5):343-361. PubMed ID: 31549599
[TBL] [Abstract][Full Text] [Related]
33. Cyclodextrin-based nanosponges: effective nanocarrier for tamoxifen delivery.
Torne S; Darandale S; Vavia P; Trotta F; Cavalli R
Pharm Dev Technol; 2013; 18(3):619-25. PubMed ID: 22235935
[TBL] [Abstract][Full Text] [Related]
34. Formulation and evaluation of Piroxicam nanosponge for improved internal solubility and analgesic activity.
Gaber DA; Radwan MA; Alzughaibi DA; Alail JA; Aljumah RS; Aloqla RM; Alkhalifah SA; Abdoun SA
Drug Deliv; 2023 Dec; 30(1):2174208. PubMed ID: 36744372
[TBL] [Abstract][Full Text] [Related]
35. Drug product development and pharmacological evaluation of a sparingly soluble novel camptothecin analog for peroral administration.
Nekkanti V; Karatgi P; Paruchuri S; Pillai R
Drug Deliv; 2011 May; 18(4):294-303. PubMed ID: 21214430
[TBL] [Abstract][Full Text] [Related]
36. Lyophilization monophase solution technique for improvement of the physicochemical properties of an anticancer drug, flutamide.
Elgindy N; Elkhodairy K; Molokhia A; Elzoghby A
Eur J Pharm Biopharm; 2010 Feb; 74(2):397-405. PubMed ID: 19944160
[TBL] [Abstract][Full Text] [Related]
37. The self-assembling camptothecin-tocopherol prodrug: An effective approach for formulating camptothecin.
Lu J; Liu C; Wang P; Ghazwani M; Xu J; Huang Y; Ma X; Zhang P; Li S
Biomaterials; 2015 Sep; 62():176-87. PubMed ID: 26057133
[TBL] [Abstract][Full Text] [Related]
38. Evaluation and Characterization of Curcumin-β-Cyclodextrin and Cyclodextrin-Based Nanosponge Inclusion Complexation.
Mashaqbeh H; Obaidat R; Al-Shar'i N
Polymers (Basel); 2021 Nov; 13(23):. PubMed ID: 34883577
[TBL] [Abstract][Full Text] [Related]
39. Cyclodextrin-based nanosponges: a versatile platform for cancer nanotherapeutics development.
Swaminathan S; Cavalli R; Trotta F
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Jul; 8(4):579-601. PubMed ID: 26800431
[TBL] [Abstract][Full Text] [Related]
40. Influence of cyclodextrin complexation on piroxicam gel formulations.
Jug M; Bećirević-Laćan M; Kwokal A; Cetina-Cizmek B
Acta Pharm; 2005 Sep; 55(3):223-36. PubMed ID: 16375834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
